INNMF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Dec 16 closing price
PHRRF
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Dec 17 closing price
Ad is loading...

INNMF vs PHRRF

Header iconINNMF vs PHRRF Comparison
Open Charts INNMF vs PHRRFBanner chart's image
Amplia Therapeutics
Price$0.06
Change-$0.00 (-0.00%)
Volume$11.24K
CapitalizationN/A
PharmaTher Holdings
Price$0.16
Change-$0.00 (-0.00%)
Volume$178.07K
CapitalizationN/A
INNMF vs PHRRF Comparison Chart
Loading...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INNMF vs. PHRRF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INNMF is a StrongBuy and PHRRF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (INNMF: $0.05 vs. PHRRF: $0.16)
Brand notoriety: INNMF and PHRRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INNMF: 60% vs. PHRRF: 40%
Market capitalization -- INNMF: $20.87M vs. PHRRF: $13.99M
INNMF [@Biotechnology] is valued at $20.87M. PHRRF’s [@Biotechnology] market capitalization is $13.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INNMF’s FA Score shows that 0 FA rating(s) are green whilePHRRF’s FA Score has 0 green FA rating(s).

  • INNMF’s FA Score: 0 green, 5 red.
  • PHRRF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than PHRRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INNMF’s TA Score shows that 4 TA indicator(s) are bullish while PHRRF’s TA Score has 3 bullish TA indicator(s).

  • INNMF’s TA Score: 4 bullish, 1 bearish.
  • PHRRF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, INNMF is a better buy in the short-term than PHRRF.

Price Growth

INNMF (@Biotechnology) experienced а +8.70% price change this week, while PHRRF (@Biotechnology) price change was +0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INNMF($20.9M) has a higher market cap than PHRRF($14M). INNMF YTD gains are higher at: 5.465 vs. PHRRF (-32.500).
INNMFPHRRFINNMF / PHRRF
Capitalization20.9M14M149%
EBITDAN/AN/A-
Gain YTD5.465-32.500-17%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A1.9M-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
INNMF: Fundamental Ratings
INNMF
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INNMFPHRRF
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMTI2.220.21
+10.45%
Rockwell Medical
AIRS6.290.31
+5.18%
AirSculpt Technologies
DCBO49.570.05
+0.10%
Docebo
FCX40.62-0.12
-0.29%
Freeport-McMoran
TENB41.55-0.97
-2.28%
Tenable Holdings

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
N/A
BIVI - INNMF
26%
Poorly correlated
-1.97%
HOFBF - INNMF
23%
Poorly correlated
N/A
CYTK - INNMF
23%
Poorly correlated
-2.53%
PHRRF - INNMF
20%
Poorly correlated
+0.62%
IVEVF - INNMF
15%
Poorly correlated
N/A
More

PHRRF and

Correlation & Price change

A.I.dvisor tells us that PHRRF and HOTH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHRRF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHRRF
1D Price
Change %
PHRRF100%
+0.62%
HOTH - PHRRF
24%
Poorly correlated
+1.22%
RLYB - PHRRF
20%
Poorly correlated
N/A
INNMF - PHRRF
20%
Poorly correlated
N/A
ANTX - PHRRF
20%
Poorly correlated
-0.74%
KMSTF - PHRRF
13%
Poorly correlated
N/A
More